Is ABT or DHR cheaper?

On trailing earnings, ABT is cheaper: ABT trades at a 24.56 P/E and DHR at 34.84.

Which has grown faster, ABT or DHR?

Over the past five years, ABT grew revenue faster — ABT at a 3.87% CAGR versus DHR at 2.05%.

Does ABT or DHR pay a bigger dividend?

ABT yields 2.77% and DHR yields 0.76% based on trailing dividends and the latest price.

Is ABT or DHR more profitable?

DHR runs the higher net margin — ABT at 13.91% versus DHR at 14.89%.

Which has been the better investment, ABT or DHR?

Over the past 10-year, DHR delivered the higher annualized total return — ABT at 10.72% versus DHR at 10.98%. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Danaher Corporation (DHR)

ABT leads on 12 of 17 compared metrics.

A side-by-side comparison of Abbott Laboratories and Danaher Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — ABT vs DHR

growth of $100 · last 30y

ABT +814.7%DHR +5120.3%DHR compounded faster

Log scale — wide-divergence pair

ABT DHR

ABT vs DHR: by the numbers

•ABT is the larger company ($153.59B vs $127.47B market cap).
•ABT trades at the lower earnings multiple (24.56 vs 34.84 P/E).
•DHR converts more revenue to profit (14.89% vs 13.91% net margin).
•ABT grew revenue faster over the past five years (3.87% vs 2.05% CAGR).
•ABT pays the higher dividend yield (2.77% vs 0.76%).

Which is better, ABT or DHR?

Metric tally: ABT 12 · DHR 5

It depends on what you're optimizing for:

ValueABT(lower P/E)

GrowthABT(faster 5Y revenue CAGR)

IncomeABT(higher dividend yield)

QualityABT(higher ROIC)

Valuation

Metric	ABT	DHR
P/E ratio	24.56●	34.84
Forward P/E	14.56●	19.73
P/S ratio	3.41●	5.17
P/B ratio	2.96	2.42●
PEG ratio	2.99●	87.09
EV / EBITDA	17.30●	21.20
FCF yield	4.79%●	4.13%

Profitability

Metric	ABT	DHR
Gross margin	56.38%	60.68%●
Operating margin	18.17%	20.95%●
Net margin	13.91%	14.89%●
ROE	12.06%●	6.97%
ROIC	8.43%●	5.72%

Dividends

Metric	ABT	DHR
Dividend yield	2.77%●	0.76%
Payout ratio	65.24%	26.82%

Growth (annualized)

Metric	ABT	DHR
Revenue CAGR (5Y)	3.87%●	2.05%
EPS CAGR (5Y)	8.22%●	0.40%
FCF CAGR (5Y)	-0.61%	-0.45%●
Total return CAGR (5Y)	-2.49%●	-3.38%

Frequently asked

Which is better, ABT or DHR?: It depends on your goal. value: ABT (lower P/E); growth: ABT (faster 5Y revenue CAGR); income: ABT (higher dividend yield); quality: ABT (higher ROIC). Across all compared metrics, ABT leads 12 to 5.
Is ABT or DHR cheaper?: On trailing earnings, ABT is cheaper: ABT trades at a 24.56 P/E and DHR at 34.84.
Which has grown faster, ABT or DHR?: Over the past five years, ABT grew revenue faster — ABT at a 3.87% CAGR versus DHR at 2.05%.
Does ABT or DHR pay a bigger dividend?: ABT yields 2.77% and DHR yields 0.76% based on trailing dividends and the latest price.
Is ABT or DHR more profitable?: DHR runs the higher net margin — ABT at 13.91% versus DHR at 14.89%.
Which has been the better investment, ABT or DHR?: Over the past 10-year, DHR delivered the higher annualized total return — ABT at 10.72% versus DHR at 10.98%. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full DHR analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Danaher P/E ratio Abbott Laboratories dividend yield Danaher dividend yield Abbott Laboratories ROE Danaher ROE Abbott Laboratories operating margin Danaher operating margin Abbott Laboratories revenue growth Danaher revenue growth Abbott Laboratories free cash flow Danaher free cash flow

Abbott Laboratories & Danaher appear in these rankings

Highest Dividend Yield Stocks Dividend Aristocrats Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.